March 02, 2021
A longtime biotech executive pled guilty Tuesday to trading on confidential information to get out ahead of the market and reel in profits when he learned of a planned 2017 acquisition of Dimension Therapeutics.
February 08, 2021
Boston federal prosecutors have accused an Oregon biotechnology consultant of insider trading through the use of confidential information he learned ahead of a planned 2017 acquisition of Dimension Therapeutics by another biotech firm.